BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31168591)

  • 21. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
    Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base.
    Khullar OV; Liu Y; Gillespie T; Higgins KA; Ramalingam S; Lipscomb J; Fernandez FG
    J Thorac Oncol; 2015 Nov; 10(11):1625-33. PubMed ID: 26352534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublobar resection versus lobectomy for stage I non-small cell lung cancer: an appropriate choice in elderly patients?
    Fiorelli A; Caronia FP; Daddi N; Loizzi D; Ampollini L; Ardò N; Ventura L; Carbognani P; Potenza R; Ardissone F; Sollitto F; Mattioli S; Puma F; Santini M; Ragusa M
    Surg Today; 2016 Dec; 46(12):1370-1382. PubMed ID: 27085869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of Extent of Lymph Node Evaluation on Survival for Pathologically Lymph Node Negative Non-Small Cell Lung Cancer.
    Becker DJ; Levy BP; Gold HT; Sherman SE; Makarov DV; Schreiber D; Wisnivesky JP; Pass HI
    Am J Clin Oncol; 2018 Aug; 41(8):820-825. PubMed ID: 28301349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis.
    Matsuo Y; Chen F; Hamaji M; Kawaguchi A; Ueki N; Nagata Y; Sonobe M; Morita S; Date H; Hiraoka M
    Eur J Cancer; 2014 Nov; 50(17):2932-8. PubMed ID: 25281527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer.
    Lv X; Cao J; Dai X; Rusidanmu A
    Thorac Cancer; 2018 Aug; 9(8):1026-1031. PubMed ID: 29927089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma.
    Chiang XH; Hsu HH; Hsieh MS; Chang CH; Tsai TM; Liao HC; Tsou KC; Lin MW; Chen JS
    Ann Surg Oncol; 2020 Mar; 27(3):703-715. PubMed ID: 31646453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.
    Altorki N; Wang X; Kozono D; Watt C; Landrenau R; Wigle D; Port J; Jones DR; Conti M; Ashrafi AS; Liberman M; Yasufuku K; Yang S; Mitchell JD; Pass H; Keenan R; Bauer T; Miller D; Kohman LJ; Stinchcombe TE; Vokes E
    N Engl J Med; 2023 Feb; 388(6):489-498. PubMed ID: 36780674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
    Moon MH; Moon YK; Moon SW
    Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
    Moon Y; Lee KY; Park JK
    World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 Patients.
    Samayoa AX; Pezzi TA; Pezzi CM; Greer Gay E; Asai M; Kulkarni N; Carp N; Chun SG; Putnam JB
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1005-1011. PubMed ID: 27531307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers.
    Wolf AS; Richards WG; Jaklitsch MT; Gill R; Chirieac LR; Colson YL; Mohiuddin K; Mentzer SJ; Bueno R; Sugarbaker DJ; Swanson SJ
    Ann Thorac Surg; 2011 Nov; 92(5):1819-23; discussion 1824-5. PubMed ID: 22051277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry.
    Dziedzic R; Zurek W; Marjanski T; Rudzinski P; Orlowski TM; Sawicka W; Marczyk M; Polanska J; Rzyman W
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):363-369. PubMed ID: 28402455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    Tsutani Y; Mimura T; Kai Y; Ito M; Misumi K; Miyata Y; Okada M
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1089-1096.e1. PubMed ID: 28483268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
    Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
    J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases.
    Stephens N; Rice D; Correa A; Hoffstetter W; Mehran R; Roth J; Walsh G; Vaporciyan A; Swisher S
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):607-13. PubMed ID: 24603446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?
    Mahmood S; Bilal H; Faivre-Finn C; Shah R
    Interact Cardiovasc Thorac Surg; 2013 Nov; 17(5):845-53. PubMed ID: 23900381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sublobar resection is comparable to lobectomy for screen-detected lung cancer.
    Kamel MK; Lee B; Harrison SW; Port JL; Altorki NK; Stiles BM
    J Thorac Cardiovasc Surg; 2022 Jun; 163(6):1907-1915. PubMed ID: 34281703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.